Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O3236 POSTOPERATIVE AUTOLOGOUS BLOOD SALVAGE IN TOTAL KNEE ARTHROPLASTY REDUCES HOMOLOGOUS BLOOD TRANSFUSION REQUIREMENTS – FACT OR FICTION?



Abstract

Aims: To study whether re-transfusion of autologus blood from solcotrans drains reduced banked blood transfusion requirement in primary total knee arthroplasty (TKR). Methods: 195 patients with unilateral primary TKR using the same surgical technique and implants were prospectively reviewed. Group 1: In 120 cases, solcotrans drain system used for postoperative blood salvage and reinfusion. Group 2: 75 cases had standard redivac drains. Homologous blood transfusions used if post-operative haemoglobin < 9 gm. Factors like weight and height, and pre-operative haemoglobin levels were also studied. Results: Group 1: Average blood loss: 598 ml. 88 cases (71%) had reinfusion of autologous salvaged blood, average re-transfusion: 271 ml (range: 200 Ð 1160 ml). In 29% (32 cases), there was not enough blood in solcotrans drains for re-transfusion. 29 patients (23%) required banked blood transfusion in whom average blood loss was 720 ml, average number of units transfused: 1.6. In 10 of the 29 cases, there was not enough blood in solcotrans drains for re-transfusion. Group 2: Average blood loss: 588 ml. 20 cases (26%) required banked blood transfusion in whom average blood loss was 758 ml. Average number of units transfused: 1.9. Conclusions: In our study, solcotrans system did not reduce the requirement of banked blood transfusion signiþcantly in TKR. In both groups, low levels of preop-erative haemoglobin, low weight and amount of blood loss inßuenced banked blood requirement (p< 0.05).

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.